BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10:718-726. [PMID: 19573801 DOI: 10.1016/s1470-2045(09)70082-8] [Cited by in Crossref: 552] [Cited by in F6Publishing: 281] [Article Influence: 46.0] [Reference Citation Analysis]
Number Citing Articles
1 Du S, Barcellos-Hoff MH. Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas. Semin Radiat Oncol 2013;23:242-51. [PMID: 24012338 DOI: 10.1016/j.semradonc.2013.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
2 Tsang YW, Huang CC, Yang KL, Chi MS, Chiang HC, Wang YS, Andocs G, Szasz A, Li WT, Chi KH. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy. BMC Cancer 2015;15:708. [PMID: 26472466 DOI: 10.1186/s12885-015-1690-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
3 Berman AT, Simone CB 2nd. Immunotherapy in locally-advanced non-small cell lung cancer: releasing the brakes on consolidation? Transl Lung Cancer Res 2016;5:138-42. [PMID: 26958509 DOI: 10.3978/j.issn.2218-6751.2016.01.11] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
4 Hall S, Rudrawar S, Zunk M, Bernaitis N, Arora D, McDermott CM, Anoopkumar-Dukie S. Protection against Radiotherapy-Induced Toxicity. Antioxidants (Basel) 2016;5:E22. [PMID: 27399787 DOI: 10.3390/antiox5030022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 7.2] [Reference Citation Analysis]
5 Alexander GS, Palmer JD, Tuluc M, Lin J, Dicker AP, Bar-Ad V, Harshyne LA, Louie J, Shaw CM, Hooper DC, Lu B. Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. J Hematol Oncol 2016;9:96. [PMID: 27663515 DOI: 10.1186/s13045-016-0328-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
6 Bertaglia V, Vallone S, Pacchiana MV, Novello S. Advanced squamous lung cancer: therapeutic options, future directions, unmet needs and results of a monocentric survey. Lung Cancer Manag 2017;6:93-107. [PMID: 30643575 DOI: 10.2217/lmt-2017-0011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Vilalta M, Rafat M, Graves EE. Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci 2016;73:2999-3007. [PMID: 27022944 DOI: 10.1007/s00018-016-2210-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 10.4] [Reference Citation Analysis]
8 Balogh A, Persa E, Bogdándi EN, Benedek A, Hegyesi H, Sáfrány G, Lumniczky K. The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells. Inflamm Res 2013;62:201-12. [PMID: 23080082 DOI: 10.1007/s00011-012-0567-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
9 Grapin M, Richard C, Limagne E, Boidot R, Morgand V, Bertaut A, Derangere V, Laurent PA, Thibaudin M, Fumet JD, Crehange G, Ghiringhelli F, Mirjolet C. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination. J Immunother Cancer. 2019;7:160. [PMID: 31238970 DOI: 10.1186/s40425-019-0634-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 21.5] [Reference Citation Analysis]
10 Prezado Y, Jouvion G, Patriarca A, Nauraye C, Guardiola C, Juchaux M, Lamirault C, Labiod D, Jourdain L, Sebrie C, Dendale R, Gonzalez W, Pouzoulet F. Proton minibeam radiation therapy widens the therapeutic index for high-grade gliomas. Sci Rep 2018;8:16479. [PMID: 30405188 DOI: 10.1038/s41598-018-34796-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 11.7] [Reference Citation Analysis]
11 Demaria S, Coleman CN, Formenti SC. Radiotherapy: Changing the Game in Immunotherapy. Trends Cancer. 2016;2:286-294. [PMID: 27774519 DOI: 10.1016/j.trecan.2016.05.002] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 54.3] [Reference Citation Analysis]
12 Nagata K, Hashimoto C, Watanabe-Asaka T, Itoh K, Yasuda T, Ohta K, Oonishi H, Igarashi K, Suzuki M, Funayama T, Kobayashi Y, Nishimaki T, Katsumura T, Oota H, Ogawa M, Oga A, Ikemoto K, Itoh H, Kutsuna N, Oda S, Mitani H. In vivo 3D analysis of systemic effects after local heavy-ion beam irradiation in an animal model. Sci Rep 2016;6:28691. [PMID: 27345436 DOI: 10.1038/srep28691] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
13 Millet I, Bouic-Pages E, Hoa D, Azria D, Taourel P. Growth of breast cancer recurrences assessed by consecutive MRI. BMC Cancer 2011;11:155. [PMID: 21527002 DOI: 10.1186/1471-2407-11-155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
14 van Seggelen WO, De Vos FY, Röckmann H, van Dijk MR, Verhoeff JJC. Occurrence of an Abscopal Radiation Recall Phenomenon in a Glioblastoma Patient Treated with Nivolumab and Re-Irradiation. Case Rep Oncol 2019;12:896-900. [PMID: 31911775 DOI: 10.1159/000504698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC, Bravatà V. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm (Lond) 2015;12:14. [PMID: 25705130 DOI: 10.1186/s12950-015-0058-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 102] [Article Influence: 22.3] [Reference Citation Analysis]
16 Schmid TE, Multhoff G. Non-targeted effects of photon and particle irradiation and the interaction with the immune system. Front Oncol 2012;2:80. [PMID: 22837986 DOI: 10.3389/fonc.2012.00080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
17 Demaria S, Pilones KA, Vanpouille-Box C, Golden EB, Formenti SC. The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation. Radiat Res 2014;182:170-81. [PMID: 24937779 DOI: 10.1667/RR13500.1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 29] [Article Influence: 8.6] [Reference Citation Analysis]
18 Yoon DW, Cho JH, Choi YS, Kim J, Kim HK, Zo JI, Shim YM. Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion. Thorac Cancer 2016;7:393-8. [PMID: 27385980 DOI: 10.1111/1759-7714.12354] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
19 Sprung CN, Ivashkevich A, Forrester HB, Redon CE, Georgakilas A, Martin OA. Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects. Cancer Lett 2015;356:72-81. [PMID: 24041866 DOI: 10.1016/j.canlet.2013.09.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
20 Sridharan DM, Asaithamby A, Blattnig SR, Costes SV, Doetsch PW, Dynan WS, Hahnfeldt P, Hlatky L, Kidane Y, Kronenberg A, Naidu MD, Peterson LE, Plante I, Ponomarev AL, Saha J, Snijders AM, Srinivasan K, Tang J, Werner E, Pluth JM. Evaluating biomarkers to model cancer risk post cosmic ray exposure. Life Sci Space Res (Amst) 2016;9:19-47. [PMID: 27345199 DOI: 10.1016/j.lssr.2016.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
21 Özcan-Wahlbrink M, Schifflers C, Riemer AB. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects. Front Immunol 2019;10:2831. [PMID: 31849993 DOI: 10.3389/fimmu.2019.02831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Britschgi C, Riesterer O, Burger IA, Guckenberger M, Curioni-Fontecedro A. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer. Radiat Oncol 2018;13:102. [PMID: 29855323 DOI: 10.1186/s13014-018-1049-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
23 Kapoor V, Dadey DY, Nguyen K, Wildman SA, Hoye K, Khudanyan A, Bandara N, Rogers BE, Thotala D, Hallahan DE. Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers. J Nucl Med 2016;57:1991-7. [PMID: 27445290 DOI: 10.2967/jnumed.115.165118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
24 Benna M, Guy JB, Bosacki C, Jmour O, Ben Mrad M, Ogorodniitchouk O, Soltani S, Lan M, Daguenet E, Mery B, Sotton S, Magné N, Vallard A. Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box? Br J Radiol 2020;93:20190147. [PMID: 31971824 DOI: 10.1259/bjr.20190147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Van Hulle H, Vakaet V, Post G, Van Greveling A, Monten C, Hendrix A, Van de Vijver K, Van Dorpe J, De Visschere P, Braems G, Vandecasteele K, Denys H, De Neve W, Veldeman L. Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients. Pilot Feasibility Stud 2020;6:154. [PMID: 33062295 DOI: 10.1186/s40814-020-00693-z] [Reference Citation Analysis]
26 Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain DM, Kowolik CM, Chu P, Swiderski P, Diamond DJ, Pal SK, Raubitschek A, Kortylewski M. TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy. Cancer Res 2013;73:7211-21. [PMID: 24154870 DOI: 10.1158/0008-5472.CAN-13-1314] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
27 Patel SH, Rimner A, Cohen RB. Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors. Transl Lung Cancer Res 2017;6:186-95. [PMID: 28529901 DOI: 10.21037/tlcr.2017.03.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
28 Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy 2019;18:29-37. [PMID: 30361045 DOI: 10.1016/j.brachy.2018.08.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
29 Yang SX, Polley EC. Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up. Breast Cancer Res Treat 2019;175:287-95. [PMID: 30746635 DOI: 10.1007/s10549-019-05142-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Son CH, Lee HR, Koh EK, Shin DY, Bae JH, Yang K, Park YS. Combination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cells. Sci Rep 2016;6:32470. [PMID: 27671170 DOI: 10.1038/srep32470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Castle KD, Chen M, Wisdom AJ, Kirsch DG. Genetically engineered mouse models for studying radiation biology. Transl Cancer Res 2017;6:S900-13. [PMID: 30733931 DOI: 10.21037/tcr.2017.06.19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
32 Nikitaki Z, Pariset E, Sudar D, Costes SV, Georgakilas AG. In Situ Detection of Complex DNA Damage Using Microscopy: A Rough Road Ahead. Cancers (Basel) 2020;12:E3288. [PMID: 33172046 DOI: 10.3390/cancers12113288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Morris ZS, Wang AZ, Knox SJ. The Radiobiology of Radiopharmaceuticals. Semin Radiat Oncol 2021;31:20-7. [PMID: 33246632 DOI: 10.1016/j.semradonc.2020.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Herskind C, Barcellos-Hoff MH. Editorial: Cell Signaling Mediating Critical Radiation Responses. Front Oncol 2021;11:695355. [PMID: 34041040 DOI: 10.3389/fonc.2021.695355] [Reference Citation Analysis]
35 Chicas-Sett R, Morales-Orue I, Rodriguez-Abreu D, Lara-Jimenez P. Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review. Clin Transl Radiat Oncol 2018;9:5-11. [PMID: 29594244 DOI: 10.1016/j.ctro.2017.12.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
36 Soto-Pantoja DR, Isenberg JS, Roberts DD. Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation. J Genet Syndr Gene Ther 2011;2:1000105. [PMID: 22685691 DOI: 10.4172/2157-7412.1000105] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
37 Lhuillier C, Rudqvist NP, Elemento O, Formenti SC, Demaria S. Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. Genome Med 2019;11:40. [PMID: 31221199 DOI: 10.1186/s13073-019-0653-7] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 32.5] [Reference Citation Analysis]
38 Pan S, Wang J, Wu A, Guo Z, Wang Z, Zheng L, Dai Y, Zhu L, Nie J, Hei TK, Zhou G, Li Y, Li B, Hu W. Radiation Exposure-Induced Changes in the Immune Cells and Immune Factors of Mice With or Without Primary Lung Tumor. Dose Response 2020;18:1559325820926744. [PMID: 32489339 DOI: 10.1177/1559325820926744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Puri S, Shafique M, Gray JE. Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. Curr Treat Options Oncol 2018;19:39. [PMID: 29931587 DOI: 10.1007/s11864-018-0556-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
40 Luke JJ, Lemons JM, Karrison TG, Pitroda SP, Melotek JM, Zha Y, Al-Hallaq HA, Arina A, Khodarev NN, Janisch L, Chang P, Patel JD, Fleming GF, Moroney J, Sharma MR, White JR, Ratain MJ, Gajewski TF, Weichselbaum RR, Chmura SJ. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 2018;36:1611-8. [PMID: 29437535 DOI: 10.1200/JCO.2017.76.2229] [Cited by in Crossref: 221] [Cited by in F6Publishing: 112] [Article Influence: 73.7] [Reference Citation Analysis]
41 Adams S, Chakravarthy AB, Donach M, Spicer D, Lymberis S, Singh B, Bauer JA, Hochman T, Goldberg JD, Muggia F, Schneider RJ, Pietenpol JA, Formenti SC. Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Res Treat 2010;124:723-32. [PMID: 20878462 DOI: 10.1007/s10549-010-1181-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
42 Gong J, Le TQ, Massarelli E, Hendifar AE, Tuli R. Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination. J Immunother Cancer 2018;6:46. [PMID: 29866197 DOI: 10.1186/s40425-018-0361-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 24.0] [Reference Citation Analysis]
43 Lu M, Huang B, Hanash SM, Onuchic JN, Ben-Jacob E. Modeling putative therapeutic implications of exosome exchange between tumor and immune cells. Proc Natl Acad Sci U S A 2014;111:E4165-74. [PMID: 25246552 DOI: 10.1073/pnas.1416745111] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
44 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
45 Rodríguez-Ruiz ME, Vanpouille-Box C, Melero I, Formenti SC, Demaria S. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect. Trends Immunol 2018;39:644-55. [PMID: 30001871 DOI: 10.1016/j.it.2018.06.001] [Cited by in Crossref: 143] [Cited by in F6Publishing: 108] [Article Influence: 47.7] [Reference Citation Analysis]
46 Farias VA, Tovar I, Del Moral R, O'Valle F, Expósito J, Oliver FJ, Ruiz de Almodóvar JM. Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes. Front Oncol 2019;9:1381. [PMID: 31970082 DOI: 10.3389/fonc.2019.01381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
47 Maggio I, Manuzzi L, Lamberti G, Ricci AD, Tober N, Campana D. Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia. Cancers (Basel) 2020;12:E832. [PMID: 32235636 DOI: 10.3390/cancers12040832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
48 Serre R, Barlesi F, Muracciole X, Barbolosi D. Immunologically effective dose: a practical model for immuno-radiotherapy. Oncotarget 2018;9:31812-9. [PMID: 30159124 DOI: 10.18632/oncotarget.25746] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
49 Chen Y, Huang Z, Xing L, Meng X, Yu J. Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature. Front Oncol 2020;10:561. [PMID: 32411597 DOI: 10.3389/fonc.2020.00561] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
50 Johnsrud AJ, Jenkins SV, Jamshidi-Parsian A, Quick CM, Galhardo EP, Dings RPM, Vang KB, Narayanasamy G, Makhoul I, Griffin RJ. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations. Radiat Res 2020;194:688-97. [PMID: 33348372 DOI: 10.1667/RADE-20-00065.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Goto T. Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges. Vaccines (Basel) 2019;7:E100. [PMID: 31455032 DOI: 10.3390/vaccines7030100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
52 Takenaka W, Takahashi Y, Tamari K, Minami K, Katsuki S, Seo Y, Isohashi F, Koizumi M, Ogawa K. Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma. Cancers (Basel) 2020;12:E1546. [PMID: 32545427 DOI: 10.3390/cancers12061546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Mehraj U, Qayoom H, Mir MA. Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives. Breast Cancer 2021;28:539-55. [PMID: 33661479 DOI: 10.1007/s12282-021-01231-2] [Reference Citation Analysis]
54 Bastianpillai C, Petrides N, Shah T, Guillaumier S, Ahmed HU, Arya M. Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment. Tumour Biol 2015;36:9137-46. [PMID: 26423402 DOI: 10.1007/s13277-015-4126-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
55 Chen Y, Gao M, Huang Z, Yu J, Meng X. SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges. J Hematol Oncol 2020;13:105. [PMID: 32723363 DOI: 10.1186/s13045-020-00940-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
56 Ottosson S, Söderström K, Kjellén E, Nilsson P, Zackrisson B, Laurell G. Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study. Radiat Oncol 2014;9:160. [PMID: 25052587 DOI: 10.1186/1748-717X-9-160] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 3.1] [Reference Citation Analysis]
57 Jin J, Li Y, Zhao Q, Chen Y, Fu S, Wu J. Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression. Cell Commun Signal 2021;19:50. [PMID: 33957948 DOI: 10.1186/s12964-021-00705-2] [Reference Citation Analysis]
58 Yan Y, Kumar AB, Finnes H, Markovic SN, Park S, Dronca RS, Dong H. Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy. Front Immunol 2018;9:1739. [PMID: 30100909 DOI: 10.3389/fimmu.2018.01739] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 27.0] [Reference Citation Analysis]
59 Dünker N, Jendrossek V. Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research. Cancers (Basel) 2019;11:E1499. [PMID: 31591362 DOI: 10.3390/cancers11101499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
60 Multhoff G, Gaipl US, Niedermann G. [The role of radiotherapy in the induction of antitumor immune responses]. Strahlenther Onkol 2012;188 Suppl 3:312-5. [PMID: 22907580 DOI: 10.1007/s00066-012-0206-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
61 van den Bijgaart RJE, Schuurmans F, Fütterer JJ, Verheij M, Cornelissen LAM, Adema GJ. Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ. Front Immunol 2021;12:617365. [PMID: 33936033 DOI: 10.3389/fimmu.2021.617365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Vatner RE, Cooper BT, Vanpouille-Box C, Demaria S, Formenti SC. Combinations of immunotherapy and radiation in cancer therapy. Front Oncol. 2014;4:325. [PMID: 25506582 DOI: 10.3389/fonc.2014.00325] [Cited by in Crossref: 139] [Cited by in F6Publishing: 117] [Article Influence: 19.9] [Reference Citation Analysis]
63 Demaria S, Formenti SC. Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking? J Immunother Cancer 2016;4:29. [PMID: 27190630 DOI: 10.1186/s40425-016-0133-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 9.4] [Reference Citation Analysis]
64 Newcomb EW, Lukyanov Y, Kawashima N, Alonso-Basanta M, Wang SC, Liu M, Jure-Kunkel M, Zagzag D, Demaria S, Formenti SC. Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model. Radiat Res 2010;173:426-32. [PMID: 20334514 DOI: 10.1667/RR1904.1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
65 Krisnawan VE, Stanley JA, Schwarz JK, DeNardo DG. Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance. Cancers (Basel) 2020;12:E2916. [PMID: 33050580 DOI: 10.3390/cancers12102916] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
66 Alvaro T, de la Cruz-Merino L, Henao-Carrasco F, Villar Rodríguez JL, Vicente Baz D, Codes Manuel de Villena M, Provencio M. Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. J Biomed Biotechnol 2010;2010:846872. [PMID: 20814546 DOI: 10.1155/2010/846872] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
67 Agarwal S, Pappas L, Matsen CB, Agarwal JP. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy. Cancer Med 2020;9:8043-52. [PMID: 32918537 DOI: 10.1002/cam4.3394] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Demaria S, Formenti SC. Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol 2012;2:153. [PMID: 23112958 DOI: 10.3389/fonc.2012.00153] [Cited by in Crossref: 139] [Cited by in F6Publishing: 151] [Article Influence: 15.4] [Reference Citation Analysis]
69 Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH. Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer. Br J Cancer 2018;118:1322-8. [PMID: 29695770 DOI: 10.1038/s41416-018-0085-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
70 Colton M, Cheadle EJ, Honeychurch J, Illidge TM. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations. Radiat Oncol 2020;15:254. [PMID: 33148287 DOI: 10.1186/s13014-020-01678-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
71 Heeran AB, Dunne MR, Morrissey ME, Buckley CE, Clarke N, Cannon A, Donlon NE, Nugent TS, Durand M, Dunne C, Larkin JO, Mehigan B, McCormick P, Lynam-Lennon N, O'Sullivan J. The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses. Cancers (Basel) 2021;13:571. [PMID: 33540635 DOI: 10.3390/cancers13030571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
72 Shiao SL, Coussens LM. The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia. 2010;15:411-421. [PMID: 21161342 DOI: 10.1007/s10911-010-9194-9] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 7.9] [Reference Citation Analysis]
73 Golden EB, Frances D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti SC. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology 2014;3:e28518. [PMID: 25071979 DOI: 10.4161/onci.28518] [Cited by in Crossref: 246] [Cited by in F6Publishing: 216] [Article Influence: 35.1] [Reference Citation Analysis]
74 Chen M, Singh AK, Repasky EA. Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance. Cancers (Basel) 2020;12:E3853. [PMID: 33419318 DOI: 10.3390/cancers12123853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Ruocco MG, Pilones KA, Kawashima N, Cammer M, Huang J, Babb JS, Liu M, Formenti SC, Dustin ML, Demaria S. Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. J Clin Invest 2012;122:3718-30. [PMID: 22945631 DOI: 10.1172/JCI61931] [Cited by in Crossref: 134] [Cited by in F6Publishing: 77] [Article Influence: 14.9] [Reference Citation Analysis]
76 Filatenkov A, Baker J, Mueller AM, Kenkel J, Ahn GO, Dutt S, Zhang N, Kohrt H, Jensen K, Dejbakhsh-Jones S, Shizuru JA, Negrin RN, Engleman EG, Strober S. Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions. Clin Cancer Res 2015;21:3727-39. [PMID: 25869387 DOI: 10.1158/1078-0432.CCR-14-2824] [Cited by in Crossref: 229] [Cited by in F6Publishing: 134] [Article Influence: 38.2] [Reference Citation Analysis]
77 Oronsky B, Larson C, Reid TR, Carter CA. Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer. J Investig Med High Impact Case Rep 2018;6:2324709618786319. [PMID: 30083560 DOI: 10.1177/2324709618786319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Hlavata Z, Solinas C, De Silva P, Porcu M, Saba L, Willard-Gallo K, Scartozzi M. The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity? Target Oncol 2018;13:113-23. [PMID: 29470785 DOI: 10.1007/s11523-018-0556-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
79 Lei R, Zhao T, Li Q, Wang X, Ma H, Deng Y. Carbon Ion Irradiated Neural Injury Induced the Peripheral Immune Effects in Vitro or in Vivo. Int J Mol Sci 2015;16:28334-46. [PMID: 26633364 DOI: 10.3390/ijms161226109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
80 Crittenden M, Kohrt H, Levy R, Jones J, Camphausen K, Dicker A, Demaria S, Formenti S. Current clinical trials testing combinations of immunotherapy and radiation. Semin Radiat Oncol 2015;25:54-64. [PMID: 25481267 DOI: 10.1016/j.semradonc.2014.07.003] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 15.3] [Reference Citation Analysis]
81 Huang TY, Huang GL, Zhang CY, Zhuang BW, Liu BX, Su LY, Ye JY, Xu M, Kuang M, Xie XY. Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage. Front Chem 2020;8:1. [PMID: 32117862 DOI: 10.3389/fchem.2020.00001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 14] [Article Influence: 48.0] [Reference Citation Analysis]
82 Wu YL, Park K, Soo RA, Sun Y, Tyroller K, Wages D, Ely G, Yang JC, Mok T. INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer. BMC Cancer 2011;11:430. [PMID: 21982342 DOI: 10.1186/1471-2407-11-430] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
83 Chen M, Qiao G, Hylander BL, Mohammadpour H, Wang XY, Subjeck JR, Singh AK, Repasky EA. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat Commun 2020;11:1821. [PMID: 32286326 DOI: 10.1038/s41467-020-15676-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
84 Moreira D, Sampath S, Won H, White SV, Su YL, Alcantara M, Wang C, Lee P, Maghami E, Massarelli E, Kortylewski M. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity. J Clin Invest 2021;131:137001. [PMID: 33232304 DOI: 10.1172/JCI137001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
85 Schaue D. A Century of Radiation Therapy and Adaptive Immunity. Front Immunol. 2017;8:431. [PMID: 28443099 DOI: 10.3389/fimmu.2017.00431] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
86 Lim JY, Brockstedt DG, Lord EM, Gerber SA. Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model. Oncoimmunology 2014;3:e29028. [PMID: 25083327 DOI: 10.4161/onci.29028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
87 Fields EC, McGuire WP, Lin L, Temkin SM. Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future. Front Oncol 2017;7:177. [PMID: 28871275 DOI: 10.3389/fonc.2017.00177] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
88 Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41:503-510. [PMID: 25872878 DOI: 10.1016/j.ctrv.2015.03.011] [Cited by in Crossref: 305] [Cited by in F6Publishing: 261] [Article Influence: 50.8] [Reference Citation Analysis]
89 Wieland A, Kamphorst AO, Adsay NV, Masor JJ, Sarmiento J, Nasti TH, Darko S, Douek DC, Xue Y, Curran WJ, Lawson DH, Ahmed R. T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient. Cancer Immunol Immunother 2018;67:1767-76. [PMID: 30167863 DOI: 10.1007/s00262-018-2228-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
90 Sundahl N, Duprez F, Ost P, De Neve W, Mareel M. Effects of radiation on the metastatic process. Mol Med 2018;24:16. [PMID: 30134800 DOI: 10.1186/s10020-018-0015-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
91 Wheeler LA, Manzanera AG, Bell SD, Cavaliere R, McGregor JM, Grecula JC, Newton HB, Lo SS, Badie B, Portnow J, Teh BS, Trask TW, Baskin DS, New PZ, Aguilar LK, Aguilar-Cordova E, Chiocca EA. Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma. Neuro Oncol 2016;18:1137-45. [PMID: 26843484 DOI: 10.1093/neuonc/now002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 13.2] [Reference Citation Analysis]
92 Guipaud O, Jaillet C, Clément-Colmou K, François A, Supiot S, Milliat F. The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy. Br J Radiol 2018;91:20170762. [PMID: 29630386 DOI: 10.1259/bjr.20170762] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
93 Matsumura S, Demaria S. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation. Radiat Res 2010;173:418-25. [PMID: 20334513 DOI: 10.1667/RR1860.1] [Cited by in Crossref: 99] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
94 Zhang J, Zhang Y, Mo F, Patel G, Butterworth K, Shao C, Prise KM. The Roles of HIF-1α in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia. Front Cell Dev Biol 2021;9:637454. [PMID: 33869184 DOI: 10.3389/fcell.2021.637454] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Bruton Joe M, Truong PT. Abscopal Effect after Palliative Radiation Therapy for Metastatic Adenocarcinoma of the Esophagus. Cureus. 2018;10:e3089. [PMID: 30333943 DOI: 10.7759/cureus.3089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
96 Adusumilli PS, Cherkassky L, Villena-Vargas J, Colovos C, Servais E, Plotkin J, Jones DR, Sadelain M. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity. Sci Transl Med 2014;6:261ra151. [PMID: 25378643 DOI: 10.1126/scitranslmed.3010162] [Cited by in Crossref: 267] [Cited by in F6Publishing: 235] [Article Influence: 44.5] [Reference Citation Analysis]
97 Long J, Lin J, Wang A, Wu L, Zheng Y, Yang X, Wan X, Xu H, Chen S, Zhao H. PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. J Hematol Oncol. 2017;10:146. [PMID: 28774337 DOI: 10.1186/s13045-017-0511-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
98 Markovsky E, Budhu S, Samstein RM, Li H, Russell J, Zhang Z, Drill E, Bodden C, Chen Q, Powell SN, Merghoub T, Wolchok JD, Humm J, Deasy JO, Haimovitz-Friedman A. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models. Int J Radiat Oncol Biol Phys 2019;103:697-708. [PMID: 30342090 DOI: 10.1016/j.ijrobp.2018.10.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
99 Siva S, Kron T, Bressel M, Haas M, Mai T, Vinod S, Sasso G, Wong W, Le H, Eade T, Hardcastle N, Chesson B, Pham D, Høyer M, Montgomery R, Ball D. A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II). BMC Cancer 2016;16:183. [PMID: 26944262 DOI: 10.1186/s12885-016-2227-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
100 Carter CA, Oronsky BT, Roswarski J, Oronsky AL, Oronsky N, Scicinski J, Lybeck H, Kim MM, Lybeck M, Reid TR. No patient left behind: The promise of immune priming with epigenetic agents. Oncoimmunology 2017;6:e1315486. [PMID: 29123948 DOI: 10.1080/2162402X.2017.1315486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
101 Yasuda K, Nirei T, Sunami E, Nagawa H, Kitayama J. Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol 2011;6:49. [PMID: 21575175 DOI: 10.1186/1748-717X-6-49] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
102 Tsukui H, Horie H, Koinuma K, Ohzawa H, Sakuma Y, Hosoya Y, Yamaguchi H, Yoshimura K, Lefor AK, Sata N, Kitayama J. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model. BMC Cancer 2020;20:411. [PMID: 32397971 DOI: 10.1186/s12885-020-06893-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
103 Loeffler JS, Durante M. Charged particle therapy--optimization, challenges and future directions. Nat Rev Clin Oncol 2013;10:411-24. [PMID: 23689752 DOI: 10.1038/nrclinonc.2013.79] [Cited by in Crossref: 259] [Cited by in F6Publishing: 163] [Article Influence: 32.4] [Reference Citation Analysis]
104 Poh AR, Ernst M. Targeting Macrophages in Cancer: From Bench to Bedside. Front Oncol. 2018;8:49. [PMID: 29594035 DOI: 10.3389/fonc.2018.00049] [Cited by in Crossref: 188] [Cited by in F6Publishing: 162] [Article Influence: 62.7] [Reference Citation Analysis]
105 El-Osta H, Shahid K, Mills GM, Peddi P. Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment. Onco Targets Ther 2016;9:5101-16. [PMID: 27574451 DOI: 10.2147/OTT.S111209] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
106 Formenti SC, Demaria S. Radiation therapy to convert the tumor into an in situ vaccine. Int J Radiat Oncol Biol Phys. 2012;84:879-880. [PMID: 23078897 DOI: 10.1016/j.ijrobp.2012.06.020] [Cited by in Crossref: 164] [Cited by in F6Publishing: 136] [Article Influence: 20.5] [Reference Citation Analysis]
107 Drake CG. Combination immunotherapy approaches. Ann Oncol. 2012;23 Suppl 8:viii41-viii46. [PMID: 22918927 DOI: 10.1093/annonc/mds262] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
108 Chen X, Liao C, Chu Q, Zhou G, Lin X, Li X, Lu H, Xu B, Yue Z. Dissecting the molecular mechanism of ionizing radiation-induced tissue damage in the feather follicle. PLoS One 2014;9:e89234. [PMID: 24586618 DOI: 10.1371/journal.pone.0089234] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
109 Marconi R, Strolin S, Bossi G, Strigari L. A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger? PLoS One 2017;12:e0171559. [PMID: 28222111 DOI: 10.1371/journal.pone.0171559] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 13.8] [Reference Citation Analysis]
110 Kosinsky Y, Dovedi SJ, Peskov K, Voronova V, Chu L, Tomkinson H, Al-Huniti N, Stanski DR, Helmlinger G. Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model. J Immunother Cancer 2018;6:17. [PMID: 29486799 DOI: 10.1186/s40425-018-0327-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
111 Golden EB, Demaria S, Schiff PB, Chachoua A, Formenti SC. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res. 2013;1:365-372. [PMID: 24563870 DOI: 10.1158/2326-6066.cir-13-0115] [Cited by in Crossref: 434] [Cited by in F6Publishing: 226] [Article Influence: 72.3] [Reference Citation Analysis]
112 Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L. Immune recognition of irradiated cancer cells. Immunol Rev 2017;280:220-30. [PMID: 29027232 DOI: 10.1111/imr.12568] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 12.7] [Reference Citation Analysis]
113 Ni K, Lan G, Chan C, Quigley B, Lu K, Aung T, Guo N, La Riviere P, Weichselbaum RR, Lin W. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy. Nat Commun 2018;9:2351. [PMID: 29907739 DOI: 10.1038/s41467-018-04703-w] [Cited by in Crossref: 122] [Cited by in F6Publishing: 98] [Article Influence: 40.7] [Reference Citation Analysis]
114 Bagwe-Parab S, Yadav P, Kaur G, Tuli HS, Buttar HS. Therapeutic Applications of Human and Bovine Colostrum in the Treatment of Gastrointestinal Diseases and Distinctive Cancer Types: The Current Evidence. Front Pharmacol 2020;11:01100. [PMID: 33071773 DOI: 10.3389/fphar.2020.01100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
115 Berzaghi R, Ahktar MA, Islam A, Pedersen BD, Hellevik T, Martinez-Zubiaurre I. Fibroblast-Mediated Immunoregulation of Macrophage Function Is Maintained after Irradiation. Cancers (Basel) 2019;11:E689. [PMID: 31108906 DOI: 10.3390/cancers11050689] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
116 Evans T, Ciunci C, Hertan L, Gomez D. Special topics in immunotherapy and radiation therapy: reirradiation and palliation. Transl Lung Cancer Res 2017;6:119-30. [PMID: 28529895 DOI: 10.21037/tlcr.2017.04.03] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
117 Hui C, Chau B, Gan G, Stokes W, Karam SD, Amini A. Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review. Front Oncol 2021;11:592319. [PMID: 34277390 DOI: 10.3389/fonc.2021.592319] [Reference Citation Analysis]
118 Berghen C, Joniau S, Vulsteke C, Albersen M, Devos G, Rans K, Haustermans K, De Meerleer G. Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news. Ecancermedicalscience 2020;14:1036. [PMID: 32565889 DOI: 10.3332/ecancer.2020.1036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 de la Cruz-Merino L, Illescas-Vacas A, Grueso-López A, Barco-Sánchez A, Míguez-Sánchez C. Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored. Front Immunol. 2014;5:102. [PMID: 24672524 DOI: 10.3389/fimmu.2014.00102/abstract] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Lumniczky K, Candéias SM, Gaipl US, Frey B. Editorial: Radiation and the Immune System: Current Knowledge and Future Perspectives. Front Immunol 2017;8:1933. [PMID: 29410662 DOI: 10.3389/fimmu.2017.01933] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
121 Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860-875. [PMID: 23151605 DOI: 10.1038/nrc3380] [Cited by in Crossref: 902] [Cited by in F6Publishing: 787] [Article Influence: 100.2] [Reference Citation Analysis]
122 Sato H, Demaria S, Ohno T. The role of radiotherapy in the age of immunotherapy. Jpn J Clin Oncol 2021;51:513-22. [PMID: 33561212 DOI: 10.1093/jjco/hyaa268] [Reference Citation Analysis]
123 de Rosa F, Ridolfi L, Ridolfi R, Gentili G, Valmorri L, Nanni O, Petrini M, Fiammenghi L, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Riccobon A, Parisi E, Romeo A, Turci L, Guidoboni M. Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study. J Transl Med 2014;12:209. [PMID: 25053129 DOI: 10.1186/1479-5876-12-209] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
124 de la Cruz-Merino L, Lejeune M, Nogales Fernández E, Henao Carrasco F, Grueso López A, Illescas Vacas A, Pulla MP, Callau C, Álvaro T. Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications. Clin Dev Immunol 2012;2012:756353. [PMID: 22927872 DOI: 10.1155/2012/756353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
125 Gammon JM, Dold NM, Jewell CM. Improving the clinical impact of biomaterials in cancer immunotherapy. Oncotarget 2016;7:15421-43. [PMID: 26871948 DOI: 10.18632/oncotarget.7304] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 10.8] [Reference Citation Analysis]
126 Borrelli MR, Shen AH, Lee GK, Momeni A, Longaker MT, Wan DC. Radiation-Induced Skin Fibrosis: Pathogenesis, Current Treatment Options, and Emerging Therapeutics. Ann Plast Surg 2019;83:S59-64. [PMID: 31513068 DOI: 10.1097/SAP.0000000000002098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 15.0] [Reference Citation Analysis]
127 Vapiwala N, Thomas CR Jr, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD Jr, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN. Enhancing Career Paths for Tomorrow's Radiation Oncologists. Int J Radiat Oncol Biol Phys 2019;105:52-63. [PMID: 31128144 DOI: 10.1016/j.ijrobp.2019.05.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
128 Hammerich L, Binder A, Brody JD. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf. Mol Oncol 2015;9:1966-81. [PMID: 26632446 DOI: 10.1016/j.molonc.2015.10.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 13.0] [Reference Citation Analysis]
129 Corraliza-Gorjón I, Somovilla-Crespo B, Santamaria S, Garcia-Sanz JA, Kremer L. New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Front Immunol 2017;8:1804. [PMID: 29312320 DOI: 10.3389/fimmu.2017.01804] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
130 Golden EB, Pellicciotta I, Demaria S, Barcellos-Hoff MH, Formenti SC. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2012;2:88. [PMID: 22891162 DOI: 10.3389/fonc.2012.00088] [Cited by in Crossref: 148] [Cited by in F6Publishing: 136] [Article Influence: 16.4] [Reference Citation Analysis]
131 Khalili M, Daniels L, Lin A, Krebs FC, Snook AE, Bekeschus S, Bowne WB, Miller V. Non-Thermal Plasma-Induced Immunogenic Cell Death in Cancer: A Topical Review. J Phys D Appl Phys 2019;52:423001. [PMID: 31485083 DOI: 10.1088/1361-6463/ab31c1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
132 Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res 2016;22:4328-40. [PMID: 26979392 DOI: 10.1158/1078-0432.CCR-15-3026] [Cited by in Crossref: 67] [Cited by in F6Publishing: 38] [Article Influence: 13.4] [Reference Citation Analysis]
133 Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol 2021. [PMID: 34211187 DOI: 10.1038/s41577-021-00568-1] [Reference Citation Analysis]
134 Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199-208. [PMID: 24561446 DOI: 10.1038/nrc3672] [Cited by in Crossref: 849] [Cited by in F6Publishing: 608] [Article Influence: 121.3] [Reference Citation Analysis]
135 Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, Zhang T, Chachoua A, Demaria S. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med. 2018;24:1845-1851. [PMID: 30397353 DOI: 10.1038/s41591-018-0232-2] [Cited by in Crossref: 282] [Cited by in F6Publishing: 227] [Article Influence: 94.0] [Reference Citation Analysis]
136 Van Limbergen EJ, De Ruysscher DK, Olivo Pimentel V, Marcus D, Berbee M, Hoeben A, Rekers N, Theys J, Yaromina A, Dubois LJ, Lambin P. Combining radiotherapy with immunotherapy: the past, the present and the future. Br J Radiol. 2017;90:20170157. [PMID: 28541096 DOI: 10.1259/bjr.20170157] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
137 McKernan P, Virani NA, Faria GNF, Karch CG, Prada Silvy R, Resasco DE, Thompson LF, Harrison RG. Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer. Nanoscale Res Lett 2021;16:9. [PMID: 33411055 DOI: 10.1186/s11671-020-03459-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
138 Hodge JW, Sharp HJ, Gameiro SR. Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation. Cancer Biother Radiopharm 2012;27:12-22. [PMID: 22283603 DOI: 10.1089/cbr.2012.1202] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 8.7] [Reference Citation Analysis]
139 Durante M, Formenti S. Harnessing radiation to improve immunotherapy: better with particles? Br J Radiol 2020;93:20190224. [PMID: 31317768 DOI: 10.1259/bjr.20190224] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 11.5] [Reference Citation Analysis]
140 Wang Q, Li S, Qiao S, Zheng Z, Duan X, Zhu X. Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis. Front Immunol 2021;12:648652. [PMID: 34220806 DOI: 10.3389/fimmu.2021.648652] [Reference Citation Analysis]
141 Dagoglu N, Karaman S, Caglar HB, Oral EN. Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases. Cureus 2019;11:e4103. [PMID: 31057997 DOI: 10.7759/cureus.4103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
142 Farooque A, Singh N, Adhikari JS, Afrin F, Dwarakanath BS. Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice. PLoS One. 2014;9:e108131. [PMID: 25248151 DOI: 10.1371/journal.pone.0108131] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
143 Taunk NK, Rimner A, Culligan M, Friedberg JS, Brahmer J, Chaft J. Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer. Transl Lung Cancer Res 2017;6:178-85. [PMID: 28529900 DOI: 10.21037/tlcr.2017.03.05] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
144 Huang Z, Wang Y, Yao D, Wu J, Hu Y, Yuan A. Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress. Nat Commun 2021;12:145. [PMID: 33420008 DOI: 10.1038/s41467-020-20243-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
145 Sun Q, Barz M, De Geest BG, Diken M, Hennink WE, Kiessling F, Lammers T, Shi Y. Nanomedicine and macroscale materials in immuno-oncology. Chem Soc Rev 2019;48:351-81. [PMID: 30465669 DOI: 10.1039/c8cs00473k] [Cited by in Crossref: 74] [Cited by in F6Publishing: 15] [Article Influence: 37.0] [Reference Citation Analysis]
146 de Leve S, Wirsdörfer F, Jendrossek V. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects. Cancers (Basel) 2019;11:E1578. [PMID: 31623231 DOI: 10.3390/cancers11101578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
147 Lambin P, Lieverse RIY, Eckert F, Marcus D, Oberije C, van der Wiel AMA, Guha C, Dubois LJ, Deasy JO. Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy. Semin Radiat Oncol 2020;30:187-93. [PMID: 32381298 DOI: 10.1016/j.semradonc.2019.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 14.0] [Reference Citation Analysis]
148 Soukup K, Wang X. Radiation meets immunotherapy - a perfect match in the era of combination therapy? Int J Radiat Biol 2015;91:299-305. [PMID: 25630486 DOI: 10.3109/09553002.2014.995383] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
149 Antoni D, Burckel H, Noel G. Combining Radiation Therapy with ALK Inhibitors in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer (NSCLC): A Clinical and Preclinical Overview. Cancers (Basel) 2021;13:2394. [PMID: 34063424 DOI: 10.3390/cancers13102394] [Reference Citation Analysis]
150 Ottaiano A. Real practice studies in oncology: A positive perspective. World J Gastrointest Oncol 2018;10:228-30. [PMID: 30254718 DOI: 10.4251/wjgo.v10.i9.228] [Reference Citation Analysis]
151 Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol. 2011;8:151-160. [PMID: 21364688 DOI: 10.1038/nrclinonc.2010.223] [Cited by in Crossref: 432] [Cited by in F6Publishing: 375] [Article Influence: 43.2] [Reference Citation Analysis]
152 Lee HR, Son CH, Koh EK, Bae JH, Kang CD, Yang K, Park YS. Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody. Sci Rep 2017;7:11075. [PMID: 28894091 DOI: 10.1038/s41598-017-09259-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
153 Seliger B. Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity. Front Immunol 2019;10:999. [PMID: 31178856 DOI: 10.3389/fimmu.2019.00999] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
154 Weiss EM, Wunderlich R, Ebel N, Rubner Y, Schlücker E, Meyer-Pittroff R, Ott OJ, Fietkau R, Gaipl US, Frey B. Selected anti-tumor vaccines merit a place in multimodal tumor therapies. Front Oncol 2012;2:132. [PMID: 23087898 DOI: 10.3389/fonc.2012.00132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
155 Weng D, Song B, Koido S, Calderwood SK, Gong J. Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation. J Immunol. 2013;191:755-763. [PMID: 23772032 DOI: 10.4049/jimmunol.1203286] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
156 Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer 2016;16:131-44. [PMID: 26911188 DOI: 10.1038/nrc.2016.14] [Cited by in Crossref: 409] [Cited by in F6Publishing: 333] [Article Influence: 81.8] [Reference Citation Analysis]
157 Foster CC, Weichselbaum RR, Pitroda SP. Oligometastatic prostate cancer: Reality or figment of imagination? Cancer 2019;125:340-52. [PMID: 30521067 DOI: 10.1002/cncr.31860] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
158 Harrington KJ, Billingham LJ, Brunner TB, Burnet NG, Chan CS, Hoskin P, Mackay RI, Maughan TS, Macdougall J, McKenna WG, Nutting CM, Oliver A, Plummer R, Stratford IJ, Illidge T. Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Br J Cancer 2011;105:628-39. [PMID: 21772330 DOI: 10.1038/bjc.2011.240] [Cited by in Crossref: 103] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
159 de la Cruz-Merino L, Illescas-Vacas A, Grueso-López A, Barco-Sánchez A, Míguez-Sánchez C; Cancer Immunotherapies Spanish Group (GETICA). Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored. Front Immunol 2014;5:102. [PMID: 24672524 DOI: 10.3389/fimmu.2014.00102] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
160 Sundahl N, Tree A, Parker C. The Emerging Role of Local Therapy in Metastatic Prostate Cancer. Curr Oncol Rep 2020;22:2. [PMID: 31960153 DOI: 10.1007/s11912-020-0868-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
161 Tovar I, Guerrero R, López-Peñalver JJ, Expósito J, Ruiz de Almodóvar JM. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome. Cells 2020;9:E2015. [PMID: 32887260 DOI: 10.3390/cells9092015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
162 Shinde-Jadhav S, Mansure JJ, Rayes RF, Marcq G, Ayoub M, Skowronski R, Kool R, Bourdeau F, Brimo F, Spicer J, Kassouf W. Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer. Nat Commun 2021;12:2776. [PMID: 33986291 DOI: 10.1038/s41467-021-23086-z] [Reference Citation Analysis]
163 Fujiwara K, Saung MT, Jing H, Herbst B, Zarecki M, Muth S, Wu A, Bigelow E, Chen L, Li K, Jurcak N, Blair AB, Ding D, Wichroski M, Blum J, Cheadle N, Koenitzer J, Zheng L. Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer. J Immunother Cancer 2020;8:e000351. [PMID: 32675194 DOI: 10.1136/jitc-2019-000351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
164 Jagodinsky JC, Jin WJ, Bates AM, Hernandez R, Grudzinski JJ, Marsh IR, Chakravarty I, Arthur IS, Zangl LM, Brown RJ, Nystuen EJ, Emma SE, Kerr C, Carlson PM, Sriramaneni RN, Engle JW, Aluicio-Sarduy E, Barnhart TE, Le T, Kim K, Bednarz BP, Weichert JP, Patel RB, Morris ZS. Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy. Theranostics 2021;11:6120-37. [PMID: 33995649 DOI: 10.7150/thno.54881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 Jagodinsky JC, Harari PM, Morris ZS. The Promise of Combining Radiation Therapy With Immunotherapy. Int J Radiat Oncol Biol Phys 2020;108:6-16. [PMID: 32335187 DOI: 10.1016/j.ijrobp.2020.04.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
166 Yasuda T, Kamahori M, Nagata K, Watanabe-Asaka T, Suzuki M, Funayama T, Mitani H, Oda S. Abscopal Activation of Microglia in Embryonic Fish Brain Following Targeted Irradiation with Heavy-Ion Microbeam. Int J Mol Sci 2017;18:E1428. [PMID: 28677658 DOI: 10.3390/ijms18071428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
167 Sun X, Gan L, Na A, Ge L, Chen B, Liu J. Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer. J Oncol 2019;2019:1483406. [PMID: 31871454 DOI: 10.1155/2019/1483406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
168 Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer. 2011;11:64. [PMID: 21306650 DOI: 10.1186/1471-2407-11-64] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.0] [Reference Citation Analysis]
169 Courtier N, Gambling T, Barrett-Lee P, Mason MD. Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy. Adv Radiat Oncol 2018;3:552-8. [PMID: 30370355 DOI: 10.1016/j.adro.2018.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
170 Bhalla N, Brooker R, Brada M. Combining immunotherapy and radiotherapy in lung cancer. J Thorac Dis 2018;10:S1447-60. [PMID: 29951296 DOI: 10.21037/jtd.2018.05.107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
171 Boustani J, Grapin M, Laurent PA, Apetoh L, Mirjolet C. The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response. Cancers (Basel) 2019;11:E860. [PMID: 31226866 DOI: 10.3390/cancers11060860] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 12.5] [Reference Citation Analysis]
172 Chen J, Wang Z, Ding Y, Huang F, Huang W, Lan R, Chen R, Wu B, Fu L, Yang Y, Liu J, Hong J, Zhang W, Zhang L. Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression. Front Oncol 2020;10:4. [PMID: 32117702 DOI: 10.3389/fonc.2020.00004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
173 Sánchez-Castillo A, Vooijs M, Kampen KR. Linking Serine/Glycine Metabolism to Radiotherapy Resistance. Cancers (Basel) 2021;13:1191. [PMID: 33801846 DOI: 10.3390/cancers13061191] [Reference Citation Analysis]
174 Lubelski D, Tanenbaum JE, Purvis TE, Bomberger TT, Goodwin CR, Laufer I, Sciubba DM. Predictors of complications and readmission following spinal stereotactic radiosurgery. CNS Oncol 2017. [PMID: 28718316 DOI: 10.2217/cns-2016-0048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
175 Butts C, Maksymiuk A, Goss G, Soulières D, Marshall E, Cormier Y, Ellis PM, Price A, Sawhney R, Beier F. Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. J Cancer Res Clin Oncol. 2011;137:1337-1342. [PMID: 21744082 DOI: 10.1007/s00432-011-1003-3] [Cited by in Crossref: 126] [Cited by in F6Publishing: 106] [Article Influence: 12.6] [Reference Citation Analysis]
176 Tsoutsou PG, Zaman K, Martin Lluesma S, Cagnon L, Kandalaft L, Vozenin MC. Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity. Front Oncol 2018;8:609. [PMID: 30619749 DOI: 10.3389/fonc.2018.00609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
177 Adams S, Kozhaya L, Martiniuk F, Meng TC, Chiriboga L, Liebes L, Hochman T, Shuman N, Axelrod D, Speyer J, Novik Y, Tiersten A, Goldberg JD, Formenti SC, Bhardwaj N, Unutmaz D, Demaria S. Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res 2012;18:6748-57. [PMID: 22767669 DOI: 10.1158/1078-0432.CCR-12-1149] [Cited by in Crossref: 133] [Cited by in F6Publishing: 69] [Article Influence: 14.8] [Reference Citation Analysis]
178 Mujoo K, Hunt CR, Pandita RK, Ferrari M, Krishnan S, Cooke JP, Hahn S, Pandita TK. Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes. Mol Cancer Res 2018;16:1209-14. [PMID: 29592896 DOI: 10.1158/1541-7786.MCR-17-0743] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
179 Takahashi Y, Matsutani N, Nakayama T, Dejima H, Uehara H, Kawamura M. Immunological effect of local ablation combined with immunotherapy on solid malignancies. Chin J Cancer 2017;36:49. [PMID: 28592286 DOI: 10.1186/s40880-017-0216-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
180 de Vries NL, Swets M, Vahrmeijer AL, Hokland M, Kuppen PJ. The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment. Int J Mol Sci 2016;17:E1030. [PMID: 27367680 DOI: 10.3390/ijms17071030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
181 Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol 2017;18:e266-73. [PMID: 28456586 DOI: 10.1016/S1470-2045(17)30252-8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 32] [Article Influence: 21.3] [Reference Citation Analysis]
182 Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem GE, Van Gestel D. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers (Basel) 2019;11:E1093. [PMID: 31374895 DOI: 10.3390/cancers11081093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
183 Bozorgmehr F, Chung I, Christopoulos P, Krisam J, Schneider MA, Brückner L, Mueller DW, Thomas M, Rieken S. Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial. BMC Cancer 2020;20:806. [PMID: 32842974 DOI: 10.1186/s12885-020-07264-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
184 Deloch L, Derer A, Hartmann J, Frey B, Fietkau R, Gaipl US. Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation. Front Oncol 2016;6:141. [PMID: 27379203 DOI: 10.3389/fonc.2016.00141] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 16.0] [Reference Citation Analysis]
185 Protopapa M, Kouloulias V, Kougioumtzopoulou A, Liakouli Z, Papadimitriou C, Zygogianni A. Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy. Clin Transl Oncol 2020;22:447-56. [PMID: 31254253 DOI: 10.1007/s12094-019-02165-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
186 Kohl V, Drews O, Costina V, Bierbaum M, Jawhar A, Roehl H, Weiss C, Brendel S, Kleiner H, Flach J, Spiess B, Seifarth W, Nowak D, Hofmann WK, Fabarius A, Popp HD. Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells. Int J Mol Sci 2021;22:5844. [PMID: 34072546 DOI: 10.3390/ijms22115844] [Reference Citation Analysis]
187 Leary R, Gardner RB, Mockbee C, Roychowdhury DF. Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies. Cureus 2019;11:e4276. [PMID: 31157137 DOI: 10.7759/cureus.4276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
188 López Alfonso JC, Poleszczuk J, Walker R, Kim S, Pilon-Thomas S, Conejo-Garcia JJ, Soliman H, Czerniecki B, Harrison LB, Enderling H. Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery. JCO Clin Cancer Inform 2019;3:1-16. [PMID: 30964698 DOI: 10.1200/CCI.18.00075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
189 Mohye El-Din AA, Abdelrazzak AB, Ahmed MT, El-Missiry MA. Radiation induced bystander effects in the spleen of cranially-irradiated rats. Br J Radiol 2017;90:20170278. [PMID: 28937261 DOI: 10.1259/bjr.20170278] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
190 Zhang P, Darmon A, Marill J, Mohamed Anesary N, Paris S. Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model. Int J Nanomedicine 2020;15:3843-50. [PMID: 32581534 DOI: 10.2147/IJN.S250490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
191 Habets TH, Oth T, Houben AW, Huijskens MJ, Senden-Gijsbers BL, Schnijderberg MC, Brans B, Dubois LJ, Lambin P, De Saint-Hubert M, Germeraad WT, Tilanus MG, Mottaghy FM, Bos GM, Vanderlocht J. Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response. PLoS One 2016;11:e0159515. [PMID: 27427766 DOI: 10.1371/journal.pone.0159515] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
192 Hernández ÁP, Juanes-Velasco P, Landeira-Viñuela A, Bareke H, Montalvillo E, Góngora R, Fuentes M. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers (Basel) 2021;13:2821. [PMID: 34198850 DOI: 10.3390/cancers13112821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
193 Kim N, Yu JI, Park HC, Yoo GS, Choi C, Hong JY, Lim HY, Lee J, Choi MS, Lee JE, Kim K. Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab. Cancer Immunol Immunother 2021;70:1593-603. [PMID: 33231725 DOI: 10.1007/s00262-020-02794-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
194 Clement S, Campbell JM, Deng W, Guller A, Nisar S, Liu G, Wilson BC, Goldys EM. Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer. Adv Sci (Weinh) 2020;7:2003584. [PMID: 33344143 DOI: 10.1002/advs.202003584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
195 Demaria S, Formenti SC. Role of T lymphocytes in tumor response to radiotherapy. Front Oncol 2012;2:95. [PMID: 22937524 DOI: 10.3389/fonc.2012.00095] [Cited by in Crossref: 73] [Cited by in F6Publishing: 87] [Article Influence: 8.1] [Reference Citation Analysis]
196 Ionna F, Bossi P, Guida A, Alberti A, Muto P, Salzano G, Ottaiano A, Maglitto F, Leopardo D, De Felice M, Longo F, Tafuto S, Della Vittoria Scarpati G, Perri F. Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies. Cancers (Basel) 2021;13:2371. [PMID: 34069092 DOI: 10.3390/cancers13102371] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
197 Seebacher NA, Stacy AE, Porter GM, Merlot AM. Clinical development of targeted and immune based anti-cancer therapies. J Exp Clin Cancer Res 2019;38:156. [PMID: 30975211 DOI: 10.1186/s13046-019-1094-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 29.0] [Reference Citation Analysis]
198 Asna N, Livoff A, Batash R, Debbi R, Schaffer P, Rivkind T, Schaffer M. Radiation therapy and immunotherapy-a potential combination in cancer treatment. Curr Oncol 2018;25:e454-60. [PMID: 30464697 DOI: 10.3747/co.25.4002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
199 Yu X, Liu B, Zhang N, Wang Q, Cheng G. Immune Response: A Missed Opportunity Between Vitamin D and Radiotherapy. Front Cell Dev Biol 2021;9:646981. [PMID: 33928081 DOI: 10.3389/fcell.2021.646981] [Reference Citation Analysis]
200 Ebner DK, Tinganelli W, Helm A, Bisio A, Yamada S, Kamada T, Shimokawa T, Durante M. The Immunoregulatory Potential of Particle Radiation in Cancer Therapy. Front Immunol 2017;8:99. [PMID: 28220126 DOI: 10.3389/fimmu.2017.00099] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 9.5] [Reference Citation Analysis]
201 Mann J, Ramakrishna R, Magge R, Wernicke AG. Advances in Radiotherapy for Glioblastoma. Front Neurol 2017;8:748. [PMID: 29379468 DOI: 10.3389/fneur.2017.00748] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 16.7] [Reference Citation Analysis]
202 Flamant S, Tamarat R. Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure. Radiat Res 2016;186:203-18. [PMID: 27459703 DOI: 10.1667/RR14482.1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
203 Pandya PH, Murray ME, Pollok KE, Renbarger JL. The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. J Immunol Res 2016;2016:4273943. [PMID: 28116316 DOI: 10.1155/2016/4273943] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 14.8] [Reference Citation Analysis]
204 Zhou Z, Deng H, Yang W, Wang Z, Lin L, Munasinghe J, Jacobson O, Liu Y, Tang L, Ni Q, Kang F, Liu Y, Niu G, Bai R, Qian C, Song J, Chen X. Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging. Nat Commun 2020;11:3032. [PMID: 32541769 DOI: 10.1038/s41467-020-16771-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
205 Wirsdörfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, Lüdemann L, Stuschke M, Jendrossek V. Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells. Radiat Oncol 2014;9:98. [PMID: 24766907 DOI: 10.1186/1748-717X-9-98] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
206 Boustani J, Derangère V, Bertaut A, Adotevi O, Morgand V, Charon-Barra C, Ghiringhelli F, Mirjolet C. Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer. Cells 2020;9:E2071. [PMID: 32927784 DOI: 10.3390/cells9092071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Marconi R, Serafini A, Giovanetti A, Bartoleschi C, Pardini MC, Bossi G, Strigari L. Cytokine Modulation in Breast Cancer Patients Undergoing Radiotherapy: A Revision of the Most Recent Studies. Int J Mol Sci 2019;20:E382. [PMID: 30658426 DOI: 10.3390/ijms20020382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
208 Renner M, Feng R, Springer D, Chen MK, Ntamack A, Espina A, Saligan LN. A murine model of peripheral irradiation-induced fatigue. Behav Brain Res 2016;307:218-26. [PMID: 27012391 DOI: 10.1016/j.bbr.2016.03.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
209 Gao D, Li S. Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation. Pathol Oncol Res 2014;20:27-42. [PMID: 24357158 DOI: 10.1007/s12253-013-9734-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
210 Carvalho HA, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo) 2018;73:e557s. [PMID: 30540123 DOI: 10.6061/clinics/2018/e557s] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
211 Gerber SA, Sedlacek AL, Cron KR, Murphy SP, Frelinger JG, Lord EM. IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. Am J Pathol 2013;182:2345-54. [PMID: 23583648 DOI: 10.1016/j.ajpath.2013.02.041] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]
212 Daniel S, Nylander V, Ingerslev LR, Zhong L, Fabre O, Clifford B, Johnston K, Cohn RJ, Barres R, Simar D. T cell epigenetic remodeling and accelerated epigenetic aging are linked to long-term immune alterations in childhood cancer survivors. Clin Epigenetics 2018;10:138. [PMID: 30400990 DOI: 10.1186/s13148-018-0561-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
213 Zhuang Y, Yuan BY, Chen GW, Zhao XM, Hu Y, Zhu WC, Zeng ZC, Chen YX. Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma. Front Oncol 2019;9:896. [PMID: 31552194 DOI: 10.3389/fonc.2019.00896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
214 Seol KH, Bong SH, Kang DH, Kim JW. Factors Associated with the Quality of Life of Patients with Cancer Undergoing Radiotherapy. Psychiatry Investig 2021;18:80-7. [PMID: 33460533 DOI: 10.30773/pi.2020.0286] [Reference Citation Analysis]
215 Filatenkov A, Baker J, Müller AM, Ahn GO, Kohrt H, Dutt S, Jensen K, Dejbakhsh-Jones S, Negrin RS, Shizuru JA, Engleman EG, Strober S. Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion. Radiat Res 2014;182:163-9. [PMID: 24992165 DOI: 10.1667/RR13471.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
216 Mozdarani H. Biological complexities in radiation carcinogenesis and cancer radiotherapy: impact of new biological paradigms. Genes (Basel) 2012;3:90-114. [PMID: 24704845 DOI: 10.3390/genes3010090] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
217 Guo G, Cui Y. New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy. J Immunother Cancer 2015;3:9. [PMID: 25806108 DOI: 10.1186/s40425-015-0053-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
218 Macià I Garau M. Radiobiology of stereotactic body radiation therapy (SBRT). Rep Pract Oncol Radiother 2017;22:86-95. [PMID: 28490978 DOI: 10.1016/j.rpor.2017.02.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
219 Franke AJ, Skelton WP, Starr JS, Parekh H, Lee JJ, Overman MJ, Allegra C, George TJ. Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches. J Natl Cancer Inst 2019;111:1131-41. [PMID: 31322663 DOI: 10.1093/jnci/djz093] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 35.0] [Reference Citation Analysis]
220 Durante M. New challenges in high-energy particle radiobiology. Br J Radiol 2014;87:20130626. [PMID: 24198199 DOI: 10.1259/bjr.20130626] [Cited by in Crossref: 85] [Cited by in F6Publishing: 57] [Article Influence: 12.1] [Reference Citation Analysis]
221 Tada N, Kawai K, Tsuno NH, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Oba K, Watanabe T. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets. World J Surg Oncol. 2015;13:30. [PMID: 25890185 DOI: 10.1186/s12957-014-0418-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
222 Huang J, Wang QJ, Yang S, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro. J Immunother 2011;34:327-35. [PMID: 21499130 DOI: 10.1097/CJI.0b013e318216983d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
223 Kaplan MA, Kucukoner M, Alpagat G, Isikdogan A. Tumor lysis syndrome during radiotherapy for prostate cancer with bone and bone marrow metastases without visceral metastasis. Ann Saudi Med 2012;32:306-8. [PMID: 22588444 DOI: 10.5144/0256-4947.2012.306-308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
224 McGovern K, Ghaly M, Esposito M, Barnaby K, Seetharamu N. Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review. Future Sci OA 2019;5:FSO378. [PMID: 31245041 DOI: 10.2144/fsoa-2018-0123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
225 Grassberger C, Shinnick D, Yeap BY, Tracy M, G Ellsworth S, Hess CB, Weyman EA, Gallotto SL, Lawell MP, Bajaj B, Ebb DH, Ioakeim-Ioannidou M, Loeffler JS, MacDonald SM, Tarbell NJ, Yock TI. Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma. Int J Radiat Oncol Biol Phys 2021;110:1044-52. [PMID: 33556478 DOI: 10.1016/j.ijrobp.2021.01.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, Babb JS, Lonning SM, DeWyngaert JK, Formenti SC, Barcellos-Hoff MH. TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res 2011;17:6754-65. [PMID: 22028490 DOI: 10.1158/1078-0432.CCR-11-0544] [Cited by in Crossref: 164] [Cited by in F6Publishing: 86] [Article Influence: 16.4] [Reference Citation Analysis]
227 Lyu J, Yisikandaer A, Li T, Zhang X, Wang X, Tian Z, Chen L, Lu B, Chen H, Yang J, Wang Q, Zhang J, Ma Y, Liu R, Liu R, Hage A, Lang J. Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China. Cancer Med 2020;9:7460-8. [PMID: 32841543 DOI: 10.1002/cam4.3409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Mohiuddin M, Park H, Hallmeyer S, Richards J. High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma. Cureus 2015;7:e417. [PMID: 26848410 DOI: 10.7759/cureus.417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
229 Zhai Z, Wang Z, Jin M, Zhang K. Peripheral blood CD45RO+T cells is a predictor of the effectiveness of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Medicine (Baltimore) 2021;100:e26214. [PMID: 34160385 DOI: 10.1097/MD.0000000000026214] [Reference Citation Analysis]
230 Spaas M, Sundahl N, Hulstaert E, Kruse V, Rottey S, De Maeseneer D, Surmont V, Meireson A, Brochez L, Reynders D, Goetghebeur E, Van den Begin R, Van Gestel D, Renard V, Dirix P, Mestdagh P, Ost P. Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial. BMC Cancer 2021;21:514. [PMID: 33962592 DOI: 10.1186/s12885-021-08088-w] [Reference Citation Analysis]
231 Ohguri T, Kakinouchi S, Imada H, Matsuyama A, Yahara K, Nakahara S, Hohchi N, Suzuki H, Korogi Y. Pediatric nasopharyngeal cancer with repeated oligometastases involving the bone, liver and distant lymph nodes who achieved cure after radiotherapy. Nagoya J Med Sci 2020;82:135-41. [PMID: 32273642 DOI: 10.18999/nagjms.82.1.135] [Reference Citation Analysis]
232 Meng G, Wuest M, Tang X, Dufour J, Zhao Y, Curtis JM, McMullen TPW, Murray D, Wuest F, Brindley DN. Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle. Cancers (Basel) 2019;11:E1816. [PMID: 31752313 DOI: 10.3390/cancers11111816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
233 Demaria S, Pilones KA, Formenti SC, Dustin ML. Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment. Oncoimmunology. 2013;2:e23127. [PMID: 23802063 DOI: 10.4161/onci.23127] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
234 Buchwald ZS, Nasti TH, Lee J, Eberhardt CS, Wieland A, Im SJ, Lawson D, Curran W, Ahmed R, Khan MK. Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. J Immunother Cancer 2020;8:e000867. [PMID: 33028691 DOI: 10.1136/jitc-2020-000867] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
235 Vanpouille-Box C, Hindré F. Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity. Front Oncol 2012;2:136. [PMID: 23087900 DOI: 10.3389/fonc.2012.00136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
236 le Guevelou J, Debaigt C, Saada-Bouzid E, Viotti J, Khalladi N, Thibouw D, Penel N, Sunyach MP, Moureau-Zabotto L, Benchalal M, Veresezan O, Ducassou A, le Pechoux C, Jolnerovski M, Bazille C, Vaur D, Escande A, Serre R, Lovera C, Thariat J. Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol. BMJ Open 2020;10:e038391. [PMID: 32967883 DOI: 10.1136/bmjopen-2020-038391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
237 Martinez-Zubiaurre I, Chalmers AJ, Hellevik T. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma. Front Immunol 2018;9:1679. [PMID: 30105016 DOI: 10.3389/fimmu.2018.01679] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
238 Alfonso JCL, Papaxenopoulou LA, Mascheroni P, Meyer-Hermann M, Hatzikirou H. On the Immunological Consequences of Conventionally Fractionated Radiotherapy. iScience 2020;23:100897. [PMID: 32092699 DOI: 10.1016/j.isci.2020.100897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
239 McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys 2018;101:1259-70. [PMID: 29891204 DOI: 10.1016/j.ijrobp.2018.04.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
240 Nakano R, Ohira M, Yano T, Imaoka Y, Tanaka Y, Ohdan H. Hepatic irradiation persistently eliminates liver resident NK cells. PLoS One. 2018;13:e0198904. [PMID: 29897952 DOI: 10.1371/journal.pone.0198904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
241 Schaue D, Xie MW, Ratikan JA, McBride WH. Regulatory T cells in radiotherapeutic responses. Front Oncol 2012;2:90. [PMID: 22912933 DOI: 10.3389/fonc.2012.00090] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
242 de Leve S, Wirsdörfer F, Jendrossek V. Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy. Front Immunol 2019;10:698. [PMID: 31024543 DOI: 10.3389/fimmu.2019.00698] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
243 Ghosh C, Luong G, Sun Y. A snapshot of the PD-1/PD-L1 pathway. J Cancer 2021;12:2735-46. [PMID: 33854633 DOI: 10.7150/jca.57334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
244 Deng G, Hu P, Zhang J, Liu Q, Liang N, Xie J, Qiao L, Luo H, Xu D, Liu F, Yu X, Liu Z, Lv Y, Zhang J. Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer. Oncotarget 2016;7:85142-50. [PMID: 27835886 DOI: 10.18632/oncotarget.13202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
245 Rekers NH, Olivo Pimentel V, Yaromina A, Lieuwes NG, Biemans R, Zegers CML, Germeraad WTV, Van Limbergen EJ, Neri D, Dubois LJ, Lambin P. The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses. Oncoimmunology 2018;7:e1414119. [PMID: 29632732 DOI: 10.1080/2162402X.2017.1414119] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
246 Vanpouille-Box C, Pilones KA, Wennerberg E, Formenti SC, Demaria S. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine 2015;33:7415-22. [PMID: 26148880 DOI: 10.1016/j.vaccine.2015.05.105] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 17.0] [Reference Citation Analysis]
247 McBride WH, Ganapathy E, Lee MH, Nesseler JP, Nguyen C, Schaue D. A perspective on the impact of radiation therapy on the immune rheostat. Br J Radiol 2017;90:20170272. [PMID: 28707537 DOI: 10.1259/bjr.20170272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
248 Wirsdörfer F, de Leve S, Jendrossek V. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity? Int J Mol Sci 2018;20:E24. [PMID: 30577587 DOI: 10.3390/ijms20010024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
249 Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 2016;11:18. [PMID: 26846932 DOI: 10.1186/s13014-016-0589-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
250 Wang YS, Liu SJ, Huang SC, Chang CC, Huang YC, Fong WL, Chi MS, Chi KH. Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy. Front Oncol 2012;2:149. [PMID: 23112956 DOI: 10.3389/fonc.2012.00149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
251 Kang J, Demaria S, Formenti S. Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer. 2016;4:51. [PMID: 27660705 DOI: 10.1186/s40425-016-0156-7] [Cited by in Crossref: 227] [Cited by in F6Publishing: 193] [Article Influence: 45.4] [Reference Citation Analysis]
252 Agoni L, Lenz J, Guha C. Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines. PLoS One 2013;8:e76472. [PMID: 24204631 DOI: 10.1371/journal.pone.0076472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
253 Du S, Lockamy V, Zhou L, Xue C, LeBlanc J, Glenn S, Shukla G, Yu Y, Dicker AP, Leeper DB, Lu Y, Lu B. Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer. Int J Radiat Oncol Biol Phys 2016;96:529-37. [PMID: 27681749 DOI: 10.1016/j.ijrobp.2016.07.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
254 Shevtsov M, Pitkin E, Ischenko A, Stangl S, Khachatryan W, Galibin O, Edmond S, Lobinger D, Multhoff G. Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer. Front Immunol 2019;10:454. [PMID: 30967859 DOI: 10.3389/fimmu.2019.00454] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
255 Goedegebuure RSA, de Klerk LK, Bass AJ, Derks S, Thijssen VLJL. Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? Front Immunol 2018;9:3107. [PMID: 30692993 DOI: 10.3389/fimmu.2018.03107] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
256 Derer A, Deloch L, Rubner Y, Fietkau R, Frey B, Gaipl US. Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015;6:505. [PMID: 26500646 DOI: 10.3389/fimmu.2015.00505] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
257 Coukos G, Tanyi J, Kandalaft LE. Opportunities in immunotherapy of ovarian cancer. Ann Oncol 2016;27 Suppl 1:i11-5. [PMID: 27141063 DOI: 10.1093/annonc/mdw084] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
258 Jiang L, Li X, Zhang J, Li W, Dong F, Chen C, Lin Q, Zhang C, Zheng F, Yan W, Zheng Y, Wu X, Xu B. Combined High-Dose LATTICE Radiation Therapy and Immune Checkpoint Blockade for Advanced Bulky Tumors: The Concept and a Case Report. Front Oncol 2020;10:548132. [PMID: 33643893 DOI: 10.3389/fonc.2020.548132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
259 Sampath S, Won H, Massarelli E, Li M, Frankel P, Vora N, Vora L, Maghami E, Kortylewski M. Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients. Oncotarget 2018;9:11279-90. [PMID: 29541413 DOI: 10.18632/oncotarget.24397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
260 Walker R, Poleszczuk J, Pilon-Thomas S, Kim S, Anderson AARA, Czerniecki BJ, Harrison LB, Moros EG, Enderling H. Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy. Sci Rep 2018;8:9474. [PMID: 29930290 DOI: 10.1038/s41598-018-27718-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
261 Li B, Jiang C, Pang L, Zou B, Ding M, Sun X, Yu J, Wang L. Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review. Front Immunol 2021;12:627197. [PMID: 33859637 DOI: 10.3389/fimmu.2021.627197] [Reference Citation Analysis]
262 Grant ML, Bollard CM. Cell therapies for hematological malignancies: don't forget non-gene-modified t cells! Blood Rev 2018;32:203-24. [PMID: 29198753 DOI: 10.1016/j.blre.2017.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
263 Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 22.0] [Reference Citation Analysis]
264 Dewan MZ, Vanpouille-Box C, Kawashima N, DiNapoli S, Babb JS, Formenti SC, Adams S, Demaria S. Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer. Clin Cancer Res 2012;18:6668-78. [PMID: 23048078 DOI: 10.1158/1078-0432.CCR-12-0984] [Cited by in Crossref: 109] [Cited by in F6Publishing: 55] [Article Influence: 12.1] [Reference Citation Analysis]
265 Datta J, Berk E, Cintolo JA, Xu S, Roses RE, Czerniecki BJ. Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. Front Immunol 2015;6:271. [PMID: 26082780 DOI: 10.3389/fimmu.2015.00271] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
266 de Araújo Farias V, O'Valle F, Lerma BA, Ruiz de Almodóvar C, López-Peñalver JJ, Nieto A, Santos A, Fernández BI, Guerra-Librero A, Ruiz-Ruiz MC, Guirado D, Schmidt T, Oliver FJ, Ruiz de Almodóvar JM. Human mesenchymal stem cells enhance the systemic effects of radiotherapy. Oncotarget 2015;6:31164-80. [PMID: 26378036 DOI: 10.18632/oncotarget.5216] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
267 Boustani J, Joseph ELM, Martin E, Benhmida S, Lecoester B, Tochet F, Mirjolet C, Chevalier C, Thibouw D, Vulquin N, Servagi S, Sun X, Adotévi O. Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood. BMC Immunol 2021;22:38. [PMID: 34144673 DOI: 10.1186/s12865-021-00429-5] [Reference Citation Analysis]
268 Chevli N, Curtis AE, Powell S, New P, Butler EB, Teh BS. Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy. Adv Radiat Oncol 2021;6:100711. [PMID: 34195498 DOI: 10.1016/j.adro.2021.100711] [Reference Citation Analysis]
269 Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys. 2012;83:1306-1310. [PMID: 22208977 DOI: 10.1016/j.ijrobp.2011.09.049] [Cited by in Crossref: 287] [Cited by in F6Publishing: 270] [Article Influence: 28.7] [Reference Citation Analysis]
270 Bos PD, Plitas G, Rudra D, Lee SY, Rudensky AY. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J Exp Med 2013;210:2435-66. [PMID: 24127486 DOI: 10.1084/jem.20130762] [Cited by in Crossref: 178] [Cited by in F6Publishing: 142] [Article Influence: 22.3] [Reference Citation Analysis]
271 Belcaid Z, Phallen JA, Zeng J, See AP, Mathios D, Gottschalk C, Nicholas S, Kellett M, Ruzevick J, Jackson C, Albesiano E, Durham NM, Ye X, Tran PT, Tyler B, Wong JW, Brem H, Pardoll DM, Drake CG, Lim M. Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model. PLoS One 2014;9:e101764. [PMID: 25013914 DOI: 10.1371/journal.pone.0101764] [Cited by in Crossref: 151] [Cited by in F6Publishing: 127] [Article Influence: 21.6] [Reference Citation Analysis]
272 Jackson CM, Kochel CM, Nirschl CJ, Durham NM, Ruzevick J, Alme A, Francica BJ, Elias J, Daniels A, Dubensky TW Jr, Lauer P, Brockstedt DG, Baxi EG, Calabresi PA, Taube JM, Pardo CA, Brem H, Pardoll DM, Lim M, Drake CG. Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination. Clin Cancer Res 2016;22:1161-72. [PMID: 26490306 DOI: 10.1158/1078-0432.CCR-15-1516] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
273 Shafique MR, Robinson LA, Antonia S. Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer. Cancer Manag Res 2018;10:931-40. [PMID: 29760563 DOI: 10.2147/CMAR.S148009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
274 Ng J, Dai T. Radiation therapy and the abscopal effect: a concept comes of age. Ann Transl Med 2016;4:118. [PMID: 27127771 DOI: 10.21037/atm.2016.01.32] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
275 Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105:256-265. [PMID: 23291374 DOI: 10.1093/jnci/djs629] [Cited by in Crossref: 595] [Cited by in F6Publishing: 524] [Article Influence: 74.4] [Reference Citation Analysis]
276 Vanpouille-Box C, Diamond JM, Pilones KA, Zavadil J, Babb JS, Formenti SC, Barcellos-Hoff MH, Demaria S. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. Cancer Res 2015;75:2232-42. [PMID: 25858148 DOI: 10.1158/0008-5472.CAN-14-3511] [Cited by in Crossref: 279] [Cited by in F6Publishing: 158] [Article Influence: 46.5] [Reference Citation Analysis]
277 Sage EK, Schmid TE, Geinitz H, Gehrmann M, Sedelmayr M, Duma MN, Combs SE, Multhoff G. Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients. Strahlenther Onkol 2017;193:648-55. [PMID: 28500490 DOI: 10.1007/s00066-017-1144-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
278 Kulcenty K, Piotrowski I, Zaleska K, Wichtowski M, Wróblewska J, Murawa D, Suchorska WM. Wound fluids collected postoperatively from patients with breast cancer induce epithelial to mesenchymal transition but intraoperative radiotherapy impairs this effect by activating the radiation-induced bystander effect. Sci Rep 2019;9:7891. [PMID: 31133667 DOI: 10.1038/s41598-019-44412-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
279 Lei H, Shi M, Xu H, Bai S, Xiong X, Wei Q, Yang L. Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations. Cancer Manag Res 2021;13:1719-31. [PMID: 33658847 DOI: 10.2147/CMAR.S288337] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Timaner M, Kotsofruk R, Raviv Z, Magidey K, Shechter D, Kan T, Nevelsky A, Daniel S, de Vries EGE, Zhang T, Kaidar-Person O, Kerbel RS, Shaked Y. Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1. Oncogene 2020;39:187-203. [PMID: 31467431 DOI: 10.1038/s41388-019-0971-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
281 Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I. Therapeutic vaccines for cancer: an overview of clinical trials. Nat Rev Clin Oncol. 2014;11:509-524. [PMID: 25001465 DOI: 10.1038/nrclinonc.2014.111] [Cited by in Crossref: 454] [Cited by in F6Publishing: 380] [Article Influence: 64.9] [Reference Citation Analysis]